National Jewish Health Partners with LabCorp on Molecular Dx | GenomeWeb
NEW YORK (GenomeWeb News) – Denver research hospital National Jewish Health will collaborate with Laboratory Corporation of America to develop and commercialize molecular diagnostic tests for respiratory, immune, and related diseases, the hospital said today.
 
The hospital and LabCorp have “established a framework for discovery, development, and commercialization of diagnostic tests,” National Jewish Health said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.